SP1 and osteoporosis: Given the potential importance of theCOLIA1 Sp1 polymorphism as a genetic marker of osteoporosis outcomes on a population level, we set out to generate large-scale evidence for these associations in a collaborative study involving 26,242 individuals from several European centers within the framework of the Genetic Markers for Osteoporosis (GENOMOS) consortium.